Company / Net Income
Xeris Biopharma Holdings, Inc. Net Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$554.0K
FY2025
5-year range
-$122.7M / $554.0K
FY2021-FY2025
Trend
+101.0%
vs FY2024
Sector context
#61 of 216
Health Care
What the data says
At $554,000, Xeris Biopharma Holdings, Inc.'s net income ranks #61 of 216 in the Health Care sector. Net Income has increased for 3 consecutive years, from -$123M in FY2022 to $554,000 in FY2025.
Based on SEC 10-K filings.
$554,000 in FY2025.
Improved from -$62M to $554,000 over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#61 of 216 in Health CareTop 28% of 216This company $554.0K Sector average $454.3M
▼
-99.9% below sector average
Key checks
Key Insights
- Xeris Biopharma Holdings, Inc.'s net income has grown for 3 consecutive years.
- In FY2025, net income increased 101.0% year-over-year.
- Ranks #61 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $554.0K | +101.0% |
| FY2024 | -$54.8M | +11.9% |
| FY2023 | -$62.3M | +49.3% |
| FY2022 | -$122.7M | +0.0% |
| FY2021 | -$122.7M | -34.7% |
| FY2020 | -$91.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026